The presence of GnRH-R is evident in limited studies of eutopic and ectopic endometrium in adenomyosis (Li et al., 2021), and treatment with GnRH analogues has shown efficacy in managing adenomyosis-associated symptoms such as pain and abnormal bleeding (Ishihara et al., 2003). This evidence concerns the gene GNRH1 and adenomyosis.